Prevalence of Fabry's Disease in a Population of Patients With Chronic Pain
DOUFABIS
1 other identifier
interventional
776
1 country
21
Brief Summary
Fabry disease is a rare inherited metabolic disorder that predominantly affects heart, kidneys and nervous system. Fabry disease has been searched in series of patients presenting different isolated signs caused by the affection of one of these organs. Acroparesthesias and chronic crises of pain of different origins are reported in the large majority of patients during the progression of the disease. Moreover, this signs are frequently inaugurating the disease. The investigators have previously performed a preliminary single-center study which permitted to identify one female patient with Fabry disease in a series of 147 consecutive patients with chronic pain tested. The investigators now propose to confirm the results of our preliminary study. The investigators plan to evaluate the prevalence of Fabry disease in a series of 1000 patients suffering from chronic pains of undetermined aetiology and consecutively recruited.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2015
Longer than P75 for not_applicable
21 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 5, 2015
CompletedFirst Submitted
Initial submission to the registry
May 18, 2015
CompletedFirst Posted
Study publicly available on registry
May 21, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 15, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 15, 2021
CompletedAugust 16, 2023
August 1, 2023
6.8 years
May 18, 2015
August 11, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Diagnosis of Fabry disease in one patient suffering from chronic pains
J1 to 2 months after inclusion
Study Arms (1)
Patients with chronic pains of unknown aetiology
OTHERInterventions
The diagnosis of Fabry disease necessitates biochemical enzymatic measures of alphagalactosidase A activity in males, and genetic analysis using direct sequencing of GLA in females.
Eligibility Criteria
You may qualify if:
- patients of both sex,
- aged from 6 to 80,
- with chronic pains of unknown aetiology including: acroparesthesias, and/or pain crises evolving more than 3 months, continued neuropathic evolving more than 3 months, and/or multiple pains evolving more than 3 months and/or recurrent abdominal crises of pain who come for a clinical visit in the pain Centres of France.
You may not qualify if:
- chronic pain of known cause
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (21)
Cs douleur chronique GHSR, CHU Sud Réunion
Saint-Pierre, La Réunion, 97448, France
CeRCa, Unité de Neuromyologie, CHU de Fort de France
FORT de France, Martinique, 97261, France
Centre Douleurs Chroniques, CH de la Côte Basque
Bayonne, 64109, France
Centre Douleurs Chroniques, CHU de Bordeaux
Bordeaux, 33076, France
Service de médecine Polyvalent, CH de La Dracénie
Draguignan, 83007, France
Anesthésie, Hôpital Raymond Poincaré
Garches, 92380, France
Centre de la douleur de l'Adulte et de l'Enfant, CHU de Grenoble
Grenoble, 38043, France
Médecine - Consultations Douleur, CH de La Réole
La Réole, 33192, France
Unité Douleur et Soins Palliatifs, CH La Rochelle-Réaunis
La Rochelle, 17019, France
Pole enfant - CETD Salengro, CHRU de Lille
Lille, 59037, France
Pôle Anesthésie Consultation douleur, CHRU de Lille
Lille, 59037, France
CETD La Timone, AP-HM
Marseille, 13385, France
Centre d'Analgésie, CHRU Lapeyronie
Montpellier, 34295, France
Centre d'Evaluation et de Traitement de la Douleur, CHU de Nîmes
Nîmes, 30029, France
Service de Médecine de la Douleur et de Médecine Palliative, Hôpital Lariboisière-APHP
Paris, 75475, France
Service de lutte contre la douleur et d'Anesthésie, CH Périgueux
Périgueux, 24 019, France
Service d'Explorations Fonctionnelles et Consultations Neurologiques, CH Lyon-Sud
Pierre-Bénite, 69495, France
Centre Antidouleurs, CHU de Reims
Reims, 51092, France
Centre de la Douleur, CHRU de Strasbourg
Strasbourg, 67091, France
Centre d'Analgésie Pédiatrique, Equipe Régionale Ressource en Soins Palliatifs-Equipe " Enfant-Do ", CHU de Toulouse
Toulouse, 31059, France
Centre d'évaluation et de traitement de la Douleur, Hôpital Pierre-Paul Ricquet
Toulouse, 31059, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Cyril GOIZET
University Hospital, Bordeaux
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 18, 2015
First Posted
May 21, 2015
Study Start
March 5, 2015
Primary Completion
December 15, 2021
Study Completion
December 15, 2021
Last Updated
August 16, 2023
Record last verified: 2023-08
Data Sharing
- IPD Sharing
- Will not share